MENU

Epstein-Barr Virus Infections: Pay Me Now or Pay Me Later

Sponsored by: DiaSorin
Speaker
  • Professor of Pediatrics and Laboratory Medicine and Pathology, University of Minnesota
    Biography
      Dr. Balfour is Professor of Pediatrics in the Division of Infectious Diseases and Professor of Laboratory Medicine and Pathology. He also serves as Principal Investigator of Clinical Virology Programs. Dr. Balfour is recognized internationally as an expert in the diagnosis and treatment of herpesvirus infections, especially those due to EBV. Dr. Balfour received his MD degree from Columbia in 1966, completed his internship and residency at the University of Minnesota and Columbia-Presbyterian Medical Center in 1968, served as a pediatrician in the Air Force at Wright-Patterson Air Base, Dayton, OH from 1968-70, and then completed a post-doctoral fellowship in Infectious Disease at the University of Minnesota in 1972. He has been on the University of Minnesota faculty ever since. He is board certified in Pediatrics.

    Abstract

    Infectious mononucleosis has been recognized as a unique disease for more than 100 years and its cause, Epstein-Barr virus (EBV), was discovered more than 50 years ago.  Yet, there is no licensed vaccine and no clear-cut effective treatment for infections due to EBV. This webinar will explain why. We will cover: the clinical findings and laboratory tests for diagnosing and staging primary EBV infection; the mechanisms EBV uses to induce cancer and autoimmune diseases, especially multiple sclerosis; research approaches to prevention of EBV infection. Essentially all of us acquire EBV during our lifetime. Is it better to get it sooner or later? What do you think?

    Learning objectives:

    • At the conclusion of this webinar, you should be better able to:
    • Evaluate the clinical findings and laboratory tests used to diagnose EBV infection.
    • Discuss the probable mechanisms of EBV-spurred cancers and autoimmune disease.
    • Assess approaches to prevention of EBV infections.

    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    DEC 05, 2019 5:00 AM PST
    C.E. CREDITS
    DEC 05, 2019 5:00 AM PST
    DATE: December 5, 2019TIME: 5:00am PST, 8:00am EST The diagnosis of an active infection by the hepatitis B virus (HBV) relies on testing for the HBV surface antigen (HBsAg). Ov...
    Loading Comments...
    Show Resources
    Attendees
    • See more